Best Insurance Stocks To Invest In 2019

These 4 Emojis Are a No-No on Wall Street

Life Expectancy Holds Steady, but Not for 95-Year-Olds

5 Uses for Life Insurance That Most People Haven’t Thought Of

Americans set the Internet ablaze speaking out on Twitter. Yet speaking live to a crowd in public is still their No. 1 fear.

To get the word from an expert on how to prepare, present and benefit from making a speech, ThinkAdvisor interviewed Bernie Swain, co-founder and chair of Washington Speakers Bureau.

Any room for adlibbing within a prepared speech?

No, especially if you tend to ramble. You’ve got to stay on-theme. If you get into side stories, you lose the audience because you’ve taken them in a different direction.

But can’t practicing too much take freshness away from one’s presentation?

Great speakers practice like a musician practices their instrument. It’s mandatory to practice but in such a way that you’re able to criticize it and get others to do the same. Practice in front of family members and your staff.  Allow them to critique your performance. I used to practice in front of my wife [WSB co-founder Paula Swain]. She’d be hard on me: “Do it again – I’m not pleased with what you’re doing.” So you need to have someone that’s honest with you and will push you to keep practicing. Then you gain confidence, and it becomes easier.

Best Insurance Stocks To Invest In 2019: CVENT, INC.(CVT)

Advisors’ Opinion:

  • [By Logan Wallace]

    CyberVein (CURRENCY:CVT) traded 7.6% lower against the US dollar during the one day period ending at 21:00 PM E.T. on June 9th. One CyberVein token can now be purchased for about $0.0625 or 0.00000853 BTC on major exchanges including Bit-Z, HitBTC and IDEX. CyberVein has a total market cap of $56.75 million and $10.82 million worth of CyberVein was traded on exchanges in the last 24 hours. During the last seven days, CyberVein has traded up 5.3% against the US dollar.

Best Insurance Stocks To Invest In 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Best Insurance Stocks To Invest In 2019: CASI Pharmaceuticals, Inc.(CASI)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub downgraded shares of CASI Pharmaceuticals (NASDAQ:CASI) from a strong-buy rating to a buy rating in a report released on Saturday morning.

  • [By Maxx Chatsko]

    Shares of CASI Pharmaceuticals (NASDAQ:CASI) jumped nearly 32% today after the small-cap pharma announced a new contract drug-manufacturing pact in China. The company now will rely on Yiling Wanzhou International Pharmaceuticals for manufacturing two drugs: entecavir and cilostazol.

Leave a Reply

Your email address will not be published. Required fields are marked *